Related Experiment Videos
Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design
Mayank D Bhavsar1, Sandip B Tiwari1, Mansoor M Amiji1
1Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, United States.
Summary
Researchers developed a nanoparticle-in-microsphere oral delivery system (NiMOS) using poly(epsilon-caprolactone) microspheres. This system effectively encapsulates therapeutic macromolecules, offering a promising approach for oral drug delivery.
Area of Science:
- Biotechnology
- Materials Science
- Pharmaceutical Sciences
Background:
- Advancements in biotechnology necessitate effective oral delivery systems for therapeutic and antigenic macromolecules.
- Existing oral delivery methods face challenges in delivering large biomolecules effectively.
Purpose of the Study:
- To develop and characterize a novel nanoparticle-in-microsphere oral delivery system (NiMOS).
- To investigate the influence of key formulation variables on the particle size of NiMOS.
- To establish a predictive model for NiMOS particle size.
Main Methods:
- Encapsulation of fluorescein isothiocyanate (FITC)-labeled gelatin nanoparticles within poly(epsilon-caprolactone) (PCL) microspheres using a double emulsion technique.
- Application of a 3(3) randomized full factorial design to study variables: polymer concentration, nanoparticle loading, and homogenization speed.
- Statistical analysis using multiple linear regression and Student's t-test.
Main Results:
- A statistical model was developed to predict NiMOS particle size based on formulation parameters.
- High polymer concentration and low homogenization speed favored larger NiMOS particles.
- High homogenization speed was crucial for achieving smaller NiMOS particles (<10 µm).
- Fluorescent microscopy confirmed successful encapsulation of gelatin nanoparticles within PCL microspheres.
Conclusions:
- The developed NiMOS system demonstrates potential for oral delivery of therapeutic and antigenic macromolecules.
- The predictive model allows for controlled fabrication of NiMOS with desired particle sizes.
- NiMOS particles under 10 µm are achievable, suitable for oral administration.